Onyx Frontier
Payments companies reported to CMS as associated with Onyx Frontier. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Onyx Frontier, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Onyx Frontier
These are the largest totals companies reported as associated with Onyx Frontier. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rhian Davies | York, PA | Cardiovascular Disease | $60,526.89 |
| Ioannis Chatzizisis | Coral Gables, FL | Cardiovascular Disease | $50,133.47 |
| Emmanouil Brilakis | Minneapolis, MN | Interventional Cardiology | $44,452.56 |
| Craig Thompson | Hartford, CT | Interventional Cardiology | $37,613.51 |
| Mitul Patel | San Diego, CA | Interventional Cardiology | $25,691.25 |
| Jaikirshan Khatri | New York, NY | Interventional Cardiology | $22,901.14 |
| Jinnette Abbott | Providence, RI | Interventional Cardiology | $21,127.08 |
| Mohamed Azeem Latib | Bronx, NY | Interventional Cardiology | $20,364.45 |
| Shailendra Singh | Allentown, PA | Interventional Cardiology | $16,742.20 |
| Leah Raj | Nashville, TN | Interventional Cardiology | $12,391.90 |
Prescribed Onyx Frontier?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.